subject: Evonik Medical Resin For Reverse Accessories Supplier "status" [print this page] Today's hot spots: Qinghai earthquake underserved Red Cross initiative to publish contributions
HC pharmaceutical industry network Evonik medicinal resin business line has a sole sponsor, was held in Shanghai to attend the ninth China's pharmaceutical and life sciences industry will be the peak year, with the government officials and leading Pharmaceutical companies The senior management of hot issues for the industry to exchange views on preparations, and to explore collaborative opportunities.
China's pharmaceutical market continued over the past few years an average annual growth rate of 20%, almost doubled every four years. Despite strong growth and good market potential, pharmaceutical companies in China face the challenge has never been reduced. "As a creative industrial group Evonik always as challenges into opportunities. We are committed to a customer's strategic partner, to participate in its product development and production process, to help its excellent Chemical industry Arts, save time and reduce costs, allowing customers to quickly seize market the product to achieve win-win. "
Evonik industrial medicinal resins business line in China, Mr. Yu is responsible for people engaged in a speech at the annual meeting, said: "Therefore, in addition to providing coating services and product development support, process optimization and production problem solving programs such as standard technology services, we will provide customers Generic Development; including feasibility studies, formulation, stability, support and follow-up field amplification technology services. In addition, Evonik is also committed to value-added formulations and product lifecycle management (LifeCycle Managment, LCM) of the R & D, aimed at new Medicine Providing innovative solutions. "
Contribution to the Chinese pharmaceutical market, for the benefit of human health and life
Keeping with global trends, won record of innovative products and solutions dedicated to meeting the market on preventive health care and medical treatment needs and create a better life for mankind. China's preparations market price competition, but because of lower production levels, new product innovation can not keep up the pace of the fast-growing market, so the level of the domestic formulations industry has lagged behind the global market. Recently, the State Food Drug Administration approval of generic drugs also raise the threshold, giving China's pharmaceutical enterprises unprecedented market challenges. On the other hand, in response to a huge population and rapid aging process, the Government has invested heavily in the development of health care reform. The development of controlled release formulations is also supported by the National Food and Drug Administration's support, as "new drugs" declaration. In addition, pharmaceutical companies market to mature CMO and OEM products will be encouraged and enabled to participate in international competition, domestic agents to improve the overall industrial level. "Evonik will seize these market opportunities, adapt our business model, thus becoming a strategic partner of our customers. In addition, we also hope that China's pharmaceutical market to make our contribution, benefit the health of human life." Mr. Ding Yu very confident.
Business model change: from Accessories Supplier to strategic partner
Evonik medicinal resin core line of business products You Teqi acrylic resin (EUDRAG IT ) product line has been developed for half a century of history. The products are widely used in the pharmaceutical sector. "Now, we hope and good suppliers and manufacturers to establish long-term relationship with suppliers and close cooperation between manufacturers to provide customers one-stop solution, not just simple accessories supply business. of course, we will continue for the Chinese pharmaceutical industry to provide high-end customers in local service. "Ding-yu talking about winning line of innovative medicinal resin business, said the future market positioning. With strong technical accumulation Evonik not only for domestic customers resin application services to customers more directly involved in the oral solid dosage forms, and targeting drug delivery systems research and development process. Through this model, we can help customers enhance R & D and production efficiency, shorten time to market drugs and enhance the product life cycle management.
Close to the customer, the localization of technical service center
Order to better serve China's pharmaceutical industry to provide localized customer services, Evonik Medical Polymers 2009, completed its expansion of China's technical service center.
Evonik Medical Resin For Reverse Accessories Supplier "status"
